公衆衛生78巻11号

2014年11月発行

特集 脳血管疾患最前線

脳血管疾患の危険因子と発症予防

著者： 村木功¹ 磯博康²

所属機関： ¹大阪がん循環器病予防センター循環器病予防部門 ²大阪大学医学系研究科公衆衛生学

ページ範囲：P.739 - P.744

　わが国における脳血管疾患の年齢調整死亡率は1960年代後半より低下傾向にあり，塩分摂取量の減少や喫煙率の減少などの食事・生活習慣の改善に加え，医療水準の向上による高血圧，高脂血症，糖尿病などの生活習慣病の疾病管理状況の改善によるものと考えられる．一方，脳血管疾患は要介護の最大の原因であり，高齢化の影響により患者数が年々増加していることから，危険因子の把握および適切な予防対策が大切である．ここでは高血圧，糖尿病，喫煙などの古典的危険因子を中心に，近年，新たな危険因子として注目されている感染症や社会経済的要因についても記述する．

参考文献

1)Peters SE, et al:Smoking as a risk factor for stroke in women compared with men:a systematic review and meta-analysis of 81 cohorts, including 3, 980, 359 individuals and 42, 401 strokes. Stroke 44(10):2821-2828, 2013

2)Oono IP, et al:Meta-analysis of the association between secondhand smoke exposure and stroke. J Public Health(Oxf)33(4):496-502, 2011

3)Woodward M, et al:Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol 34(5):1036-1045, 2005

4)Lee PN, et al:Estimating the decline in excess risk of cerebrovascular disease following quitting smoking—a systematic review based on the negative exponential model. Regul Toxicol Pharmacol 68(1):85-95, 2014

5)Ronksley PE, et al:Association of alcohol consumption with selected cardiovascular disease outcomes:a systematic review and meta-analysis. BMJ 342:d671, 2011

6)Lee CD, et al:Physical activity and stroke risk:a meta-analysis. Stroke 34(10):2475-2481, 2003

7)Lu Y, et al:Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke:a pooled analysis of 97 prospective cohorts with 1・8 million participants. Lancet 383(9921):970-983, 2014

8)Wormser D, et al:Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease:collaborative analysis of 58 prospective studies. Lancet 377(9771):1085-1095, 2011

9)Lewington S, et al:Age-specific relevance of usual blood pressure to vascular mortality:a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903-1913, 2002

10)Law MR, et al:Use of blood pressure lowering drugs in the prevention of cardiovascular disease:meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665, 2009

11)Huang Y, et al:Prehypertension and the risk of stroke:a meta-analysis. Neurology 82(13):1153-1161, 2014

12)Sipahi I, et al:Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels:a meta-analysis of randomized controlled trials. Stroke 43(2):432-440, 2012

13)Miura K, et al:Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women:a meta-analysis of 16 cohort studies. Circulation 119(14):1892-1898, 2009

14)Niiranen TJ, et al:Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure:the Finn-Home study. Hypertension 55(6):1346-1351, 2010

15)Hashimoto T, et al:Home blood pressure level, blood pressure variability, smoking, and stroke risk in Japanese men:the Ohasama study. Am J Hypertens 25(8):883-891, 2012

16)Lewington S, et al:Blood cholesterol and vascular mortality by age, sex, and blood pressure:a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370(9602):1829-1839, 2007

17)Wang X, et al:Cholesterol levels and risk of hemorrhagic stroke:a systematic review and meta-analysis. Stroke 44(7):1833-1839, 2013

18)Mihaylova B, et al:The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease:meta-analysis of individual data from 27 randomised trials. Lancet 380(9841):581-590, 2012

19)Labreuche J, et al:Plasma triglyceride levels and risk of stroke and carotid atherosclerosis:a systematic review of the epidemiological studies. Atherosclerosis 203(2):331-345, 2009

20)Lee M, et al:Effect of pre-diabetes on future risk of stroke:meta-analysis. BMJ 344:e3564, 2012

21)Sarwar N, et al:Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease:a collaborative meta-analysis of 102 prospective studies. Lancet 375(9733):2215-2222, 2010

22)Mottillo S, et al:The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56(14):1113-1132, 2010

23)Wolf PA, et al:Atrial fibrillation as an independent risk factor for stroke:the Framingham Study. Stroke 22(8):983-988, 1991

24)Nakayama T, et al:A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke 28(1):45-52, 1997

25)Tanizaki Y, et al:Incidence and risk factors for subtypes of cerebral infarction in a general population:the Hisayama study. Stroke 31(11):2616-2622, 2000

26)Ohsawa M, et al:Mortality risk attributable to atrial fibrillation in middle-aged and elderly people in the Japanese general population:nineteen-year follow-up in NIPPON DATA80. Circ J 71(6):814-819, 2007

27)Gage BF, et al:Validation of clinical classification schemes for predicting stroke:results from the National Registry of Atrial Fibrillation. JAMA 285(22):2864-2870, 2001

28)Hohnloser SH, et al:Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy:an ACTIVE W Substudy. J Am Coll Cardiol 50(22):2156-2161, 2007

29)Healey JS, et al:Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120-129, 2012

30)Assiri A, et al:Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation. Clin Ther 35(7):967-984. e2, 2013

31)Cappuccio FP, et al:Sleep duration predicts cardiovascular outcomes:a systematic review and meta-analysis of prospective studies. Eur Heart J 32(12):1484-1492, 2011

32)Vyas MV, et al:Shift work and vascular events:systematic review and meta-analysis. BMJ 345:e4800, 2012

33)Dong JY, et al:Obstructive sleep apnea and cardiovascular risk:meta-analysis of prospective cohort studies. Atherosclerosis 229(2):489-495, 2013

34)Pan A, et al:Depression and risk of stroke morbidity and mortality:a meta-analysis and systematic review. JAMA 306(11):1241-1249, 2011

35)Kerr GD, et al:Do vascular risk factors explain the association between socioeconomic status and stroke incidence:a meta-analysis. Cerebrovasc Dis 31(1):57-63, 2011

36)Smeeth L, et al:Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351(25):2611-2618, 2004

37)Clayton TC, et al:Recent respiratory infection and risk of cardiovascular disease:case-control study through a general practice database. Eur Heart J 29(1):96-103, 2008

38)Chen J, et al:Chlamydia pneumoniae infection and cerebrovascular disease:a systematic review and meta-analysis. BMC Neurol 13:183, 2013

39)Zhang S, et al:Cytotoxin-associated gene-A-seropositive virulent strains of Helicobacter pylori and atherosclerotic diseases:a systematic review. Chin Med J(Engl)121(10):946-951, 2008

40)Ikeda A, et al:The combination of Helicobacter pylori-and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese:The Japan Public Health Center-based study. Atherosclerosis 230(1):67-72, 2013

41)Lafon A, et al:Periodontal disease and stroke:a meta-analysis of cohort studies. Eur J Neurol 21(9):1155-e67, 2014

42)Elkind MS, et al:Infectious burden and risk of stroke:the northern Manhattan study. Arch Neurol 67(1)：33-38, 2010

43)Yatsuya H, et al:Development of a point-based prediction model for the incidence of total stroke:Japan public health center study. Stroke 44(5):1295-1302, 2013

44)Imano H, et al:Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population:the Circulatory Risk in Communities Study(CIRCS). Stroke 40(5):1571-1577, 2009

45)Kadota A, et al:Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity:NIPPON DATA90, 1990-2000. Diabetes Care 30(6):1533-1538, 2007

46)Chei CL, et al:Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke among Middle-Aged Japanese. Hypertens Res 31(10):1887-1894, 2008

47)Noda H, et al:The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke:the Japan public health center-based study. Hypertens Res 32(4):289-298, 2009